Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2

被引:175
作者
Jayadev, Suman [1 ]
Leverenz, James B. [1 ,2 ,3 ]
Steinbart, Ellen [1 ,5 ]
Stahl, Justin [4 ]
Klunk, William [6 ,7 ]
Yu, Cheng-En [5 ]
Bird, Thomas D. [1 ,5 ]
机构
[1] Univ Washington, Dept Neurol, Seattle, WA 98195 USA
[2] Vet Adm Puget Sound Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Seattle, WA USA
[3] Vet Adm Puget Sound Hlth Care Syst, Parkinson Dis Res Educ & Clin Ctr, Seattle, WA USA
[4] Virginia Mason Clin, Vet Adm Puget Sound Hlth Care Syst, Seattle, WA 98101 USA
[5] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Seattle, WA 98108 USA
[6] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA
[7] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA
关键词
Alzheimer's disease; presenilin; 2; human genetics; dementia; amyloid; Volga German; PRECURSOR PROTEIN GENES; LEWY BODY PATHOLOGY; VARIABLE EXPRESSION; MISSENSE MUTATIONS; ONSET; DEMENTIA; PATIENT; FAMILY; EXCITOTOXICITY; DEFICIENCY;
D O I
10.1093/brain/awq033
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutations in presenilin 2 are rare causes of early onset familial Alzheimer's disease. Eighteen presenilin 2 mutations have been reported, although not all have been confirmed pathogenic. Much remains to be learned about the range of phenotypes associated with these mutations. We have analysed our unique collection of 146 affected cases in 11 Volga German families, 101 who are likely to have the same N141I mutation in presenilin 2 (54 genotyped confirmed). We have also assessed the detailed neuropathologic findings in 18 autopsies from these families and reviewed the world's literature on other presenilin 2 mutations; presenting a novel mutation that is predicted to lead to a premature truncation codon. Seven presenilin 2 mutations reported in the literature have strong evidence for pathogenicity whereas others may be benign polymorphisms. One hundred and one affected persons, with sufficient historical information from the Volga German pedigrees (N141I mutation), had a mean onset age of 53.7 years +/- 7.8 (range 39-75) and mean age at death of 64.2 years +/- 9.8 (range 43-88). These figures overlap with and generally fall between the results from the subjects in our centre who have late onset familial Alzheimer's disease or mutations in presenilin 1. Seizures were noted in 20 (30%) of 64 subjects with detailed medical records. Two mutation carriers lived beyond age 80 without developing dementia, representing uncommon examples of decreased penetrance. Two persons had severe amyloid angiopathy and haemorrhagic stroke. Eighteen cases had detailed histopathology available and analysed at our institution. Braak stage was five or six, amyloid angiopathy and neuritic plaques were common and more than 75% had Lewy bodies in the amygdala. TAR DNA-binding protein-43 inclusions were uncommon. In addition, a 58-year-old female with a 2 year course of cognitive decline and no family history of dementia has abnormal fludeoxyglucose-positron emission tomography imaging and a novel 2 base pair deletion in presenilin 2 at nucleotide 342/343, predicted to produce a frame-shift and premature termination. We conclude that mutations in presenilin 2 are rare with only seven being well documented in the literature. The best studied N141I mutation produces an Alzheimer's disease phenotype with a wide range of onset ages overlapping both early and late onset Alzheimer's disease, often associated with seizures, high penetrance and typical Alzheimer's disease neuropathology. A novel premature termination mutation supports loss of function or haploinsufficiency as pathogenic mechanisms in presenilin 2 associated Alzheimer's disease.
引用
收藏
页码:1143 / 1154
页数:12
相关论文
共 68 条
[21]   Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency [J].
Herreman, A ;
Hartmann, D ;
Annaert, W ;
Saftig, P ;
Craessaerts, K ;
Serneels, L ;
Umans, L ;
Schrijvers, V ;
Checler, F ;
Vanderstichele, H ;
Baekelandt, V ;
Dressel, R ;
Cupers, P ;
Huylebroeck, D ;
Zwijsen, A ;
Van Leuven, F ;
De Strooper, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (21) :11872-11877
[22]   Nonsense-mediated decay approaches the clinic [J].
Holbrook, JA ;
Neu-Yilik, G ;
Hentze, MW ;
Kulozik, AE .
NATURE GENETICS, 2004, 36 (08) :801-808
[23]   Presenilins mediate phosphatidylinositol 3-kinase/AKT and ERK activation via select signaling receptors - Selectivity of PS2 in platelet-derived growth factor signaling [J].
Kang, DE ;
Yoon, IS ;
Repetto, E ;
Busse, T ;
Yermian, N ;
Ie, L ;
Koo, EH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (36) :31537-31547
[24]   Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B [J].
Klunk, WE ;
Engler, H ;
Nordberg, A ;
Wang, YM ;
Blomqvist, G ;
Holt, DP ;
Bergström, M ;
Savitcheva, I ;
Huang, GF ;
Estrada, S ;
Ausén, B ;
Debnath, ML ;
Barletta, J ;
Price, JC ;
Sandell, J ;
Lopresti, BJ ;
Wall, A ;
Koivisto, P ;
Antoni, G ;
Mathis, CA ;
Långström, B .
ANNALS OF NEUROLOGY, 2004, 55 (03) :306-319
[25]   Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees [J].
Klunk, William E. ;
Price, Julie C. ;
Mathis, Chester A. ;
Tsopelas, Nicholas D. ;
Lopresti, Brian J. ;
Ziolko, Scott K. ;
Bi, Wenzhu ;
Hoge, Jessica A. ;
Cohen, Ann D. ;
Ikonomovic, Milos D. ;
Saxton, Judith A. ;
Snitz, Beth E. ;
Pollen, Daniel A. ;
Moonis, Majaz ;
Lippa, Carol F. ;
Swearer, Joan M. ;
Johnson, Keith A. ;
Rentz, Dorene M. ;
Fischman, Alan J. ;
Aizenstein, Howard J. ;
DeKosky, Steven T. .
JOURNAL OF NEUROSCIENCE, 2007, 27 (23) :6174-6184
[26]   A novel mutation in the predicted TM2 domain of the presenilin 2 gene in a Spanish patient with late-onset Alzheimer's disease [J].
Lao, JI ;
Beyer, K ;
Fernandez-Novoa, L ;
Cacabelos, R .
NEUROGENETICS, 1998, 1 (04) :293-296
[27]   Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene [J].
Larner, AJ ;
Doran, M .
JOURNAL OF NEUROLOGY, 2006, 253 (02) :139-158
[28]  
LARNER AJ, 2009, NEUROMOL MED 0626
[29]   Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues [J].
Lee, MK ;
Slunt, HH ;
Martin, LJ ;
Thinakaran, G ;
Kim, G ;
Gandy, SE ;
Seeger, M ;
Koo, E ;
Price, DL ;
Sisodia, SS .
JOURNAL OF NEUROSCIENCE, 1996, 16 (23) :7513-7525
[30]   Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient [J].
Leverenz, James B. ;
Hamilton, Ronald ;
Tsuang, Debby W. ;
Schantz, Aimee ;
Vavrek, Darcy ;
Larson, Eric B. ;
Kukull, Walter A. ;
Lopez, Oscar ;
Galasko, Douglas ;
Masliah, Eliezer ;
Kaye, Jeffrey ;
Woltjer, Randall ;
Clark, Christopher ;
Trojanowski, John Q. ;
Montine, Thomas J. .
BRAIN PATHOLOGY, 2008, 18 (02) :220-224